Berman Capital Advisors, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$53,000
+381.8%
2,209
+390.9%
0.01%
+300.0%
Q2 2021$11,000
+120.0%
450
+167.9%
0.00%
+100.0%
Q1 2021$5,000
-28.6%
168
+8.4%
0.00%
-50.0%
Q4 2020$7,000
+40.0%
155
-9.9%
0.00%
+100.0%
Q3 2020$5,000
+25.0%
1720.0%0.00%0.0%
Q2 2020$4,000
-20.0%
1720.0%0.00%
-50.0%
Q1 2020$5,000
+25.0%
1720.0%0.00%
+100.0%
Q4 2019$4,000
+33.3%
1720.0%0.00%0.0%
Q3 2019$3,000
-25.0%
1720.0%0.00%0.0%
Q2 2019$4,000
+300.0%
1720.0%0.00%
Q1 2019$1,0000.0%1720.0%0.00%
Q4 2018$1,0001720.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders